Bicycle Therapeutics Plc Executives Sell Shares Amid Recent Price Surge

Bicycle Therapeutics PLC (BCYC) has recently disclosed that its Chief Product and Supply Chain Officer, Michael Ferguson, sold 474 shares at $7.09 per share on July 2, 2025, and 248 shares at $7.44 per share on July 3, 2025. Meanwhile, the company's Chief Executive Officer, Kevin Lee, sold 2,268 shares at $7.09 per share on July 2, 2025, and 3,193 shares at $7.44 per share on July 3, 2025. Additionally, the Chief Operating Officer, Alistair Milnes, sold 1,149 shares at $7.09 per share on July 2, 2025, and 966 shares at $7.44 per share on July 3, 2025. The company's Chief Technology Officer, Michael Skynner, sold 825 shares at $7.09 per share on July 2, 2025, and 966 shares at $7.44 per share on July 3, 2025. Furthermore, the Chief Accounting Officer, Travis Thompson, sold 100 shares at $7.44 per share on July 3, 2025, and 206 shares at $7.09 per share on July 2, 2025. Lastly, the Chief Financial Officer, Alethia Young, sold 204 shares at $7.09 per share on July 2, 2025.